Denovo Biolabs is specialized in product development through R&D and innovation for laboratory diagnostics and medical research. We develop quality Immunological tools to serve unmet demands of the industry. We are in development of biopharmaceutical technologies to deal with Global healthcare needs in terms of accessibility and affordability of drugs.
Denovo Biolabs provides wide range of customized services to Pharmaceutical, Biotechnology industries and Academic institutions.
We provide “end to end” cost effective Pharmacovigilance solutions to Pharmaceutical, Biotechnology and Medical Device companies across the globe.
Denovo Biolabs develops ELISA tools for quantitative estimation of biopharmaceutical drug level, such as humanized, monoclonal antibodies and recombinant protein for treatment of several diseases.
Denovo has also signed memorandum of understanding (MOU) with other companies to develop partnership/ collaboration in this field.